Yang VC - Search Results

1

Cell-penetrating peptides meditated encapsulation of protein therapeutics into intact red blood cells and its application.

He H, Ye J, Wang Y, Liu Q, Chung HS, Kwon YM, Shin MC, Lee K, Yang VC. He H, et al. Among authors: yang vc. J Control Release. 2014 Feb 28;176:123-132. doi: 10.1016/j.jconrel.2013.12.019. Epub 2013 Dec 27. J Control Release. 2014. PMID: 24374002 Free PMC article. Review.

2

ATTEMPTS: a heparin/protamine-based prodrug approach for delivery of thrombolytic drugs.

Liang JF, Park YJ, Song H, Li YT, Yang VC. Liang JF, et al. Among authors: yang vc. J Control Release. 2001 May 14;72(1-3):145-56. doi: 10.1016/s0168-3659(01)00270-x. J Control Release. 2001. PMID: 11389993

3

ATTEMPTS: a heparin/protamine-based delivery system for enzyme drugs.

Liang JF, Li YT, Song H, Park YJ, Naik SS, Yang VC. Liang JF, et al. Among authors: yang vc. J Control Release. 2002 Jan 17;78(1-3):67-79. doi: 10.1016/s0168-3659(01)00484-9. J Control Release. 2002. PMID: 11772450

4

Application of "ATTEMPTS" for drug delivery.

Naik SS, Liang JF, Park YJ, Lee WK, Yang VC. Naik SS, et al. Among authors: yang vc. J Control Release. 2005 Jan 3;101(1-3):35-45. doi: 10.1016/j.jconrel.2004.07.020. J Control Release. 2005. PMID: 15588892

5

A novel polyrotaxane-based intracellular delivery system for camptothecin: in vitro feasibility evaluation.

Moon C, Kwon YM, Lee WK, Park YJ, Chang LC, Yang VC. Moon C, et al. Among authors: yang vc. J Biomed Mater Res A. 2008 Jan;84(1):238-46. doi: 10.1002/jbm.a.31452. J Biomed Mater Res A. 2008. PMID: 17607767

6

Glioma selectivity of magnetically targeted nanoparticles: a role of abnormal tumor hydrodynamics.

Chertok B, David AE, Huang Y, Yang VC. Chertok B, et al. Among authors: yang vc. J Control Release. 2007 Oct 8;122(3):315-23. doi: 10.1016/j.jconrel.2007.05.030. Epub 2007 Jun 2. J Control Release. 2007. PMID: 17628157 Free PMC article.

7

In vitro assessment of a novel polyrotaxane-based drug delivery system integrated with a cell-penetrating peptide.

Moon C, Kwon YM, Lee WK, Park YJ, Yang VC. Moon C, et al. Among authors: yang vc. J Control Release. 2007 Dec 4;124(1-2):43-50. doi: 10.1016/j.jconrel.2007.08.029. Epub 2007 Sep 5. J Control Release. 2007. PMID: 17904680 Free PMC article.

8

PTD-modified ATTEMPTS system for enhanced asparaginase therapy: a proof-of-concept investigation.

Kwon YM, Li YT, Liang JF, Park YJ, Chang LC, Yang VC. Kwon YM, et al. Among authors: yang vc. J Control Release. 2008 Sep 24;130(3):252-8. doi: 10.1016/j.jconrel.2008.06.017. Epub 2008 Jun 26. J Control Release. 2008. PMID: 18652856 Free PMC article.

9

Preliminary in vivo evaluation of the protein transduction domain-modified ATTEMPTS approach in enhancing asparaginase therapy.

Li YT, Kwon YM, Spangrude GJ, Liang JF, Chung HS, Park YJ, Yang VC. Li YT, et al. Among authors: yang vc. J Biomed Mater Res A. 2009 Oct;91(1):209-20. doi: 10.1002/jbm.a.32204. J Biomed Mater Res A. 2009. PMID: 18814276

10

The ATTEMPTS delivery systems for macromolecular drugs.

Kwon YM, Li Y, Naik S, Liang JF, Huang Y, Park YJ, Yang VC. Kwon YM, et al. Among authors: yang vc. Expert Opin Drug Deliv. 2008 Nov;5(11):1255-66. doi: 10.1517/17425240802498059. Expert Opin Drug Deliv. 2008. PMID: 18976135 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

239 results

Search Page

Filters